I-Atorvastatin Calcium, Baloxavir Marboxil, Folic Acid

Mayelana NATHI

Ihlanganisa indawo engu-300,000m2 futhi isebenzisa induku engu-1450+, okuhlanganisa ochwepheshe abangaphezu kuka-300 abanobuchwepheshe obuhlukahlukene.

PRODUCT

Umlando Wenkampani

Ikhethekile ekukhiqizeni imithi nemithi yenhliziyo nemithambo yegazi, minyaka yonke ukukhiqizwa kwezinhlobo ezingama-30 zama-APIs kungaphezu kwamathani angu-3000 kanti izinhlobo eziyi-120 zemithi eqediwe zingaphezu kwamaphilisi angu-8,000.

1949
I-CPF yasungulwa edolobheni laseChangzhou ngonyaka we-1949
1984
I-API yethu, i-Hydrochlorothiazide ivunywe yi-USFDA.
2006
Uthole isitifiketi se-CEP se-Hydrochlorothiazide
2013
Kugunyazwe yi-US. Ukuhlolwa kwe-FDA izikhathi eziyisi-9, kwadlula ukuhlolwa kwe-EU GMP izikhathi ezi-3
2014
U-Nantong Chanyoo uphumelele ukuhlolwa kwe-EU GMP
2015
I-Changzhou pharma. Futhi i-Nantong Chanyoo ivunywe yi-US FDA, i-Changzhou wuxin egunyazwe yi-Chinese GMP.
2016
Amaphilisi e-Rs agunyaze ukuhlolwa kwesayithi kwe-US FDA. I-Nantong Chanyoo igunyazwe yi-PMDA.
2017
I-Changzhou pharma. Igunyazwe yi-PMDA; iqedile umhlangano wokucobelelana ngolwazi ovunywe yi-US FDA.
2018
I-China GMP igunyaze kokubili i-API kanye nemikhiqizo eqediwe futhi.
2019
I-Changzhou pharma kanye ne-Nantong Chanyoo zigunyazwe ukuhlolwa okujwayelekile kwe-FDA.

Silwela ukunikeza amakhasimende imikhiqizo esezingeni. Cela ulwazi, Isampula & Quote, Xhumana nathi!

uphenyo

Mayelana NATHI

I-Changzhou Pharmaceutical Factory (CPF)

Isitayela Sefekthri ye-CPF

I-CPF R&D

PRODUCT

I-Ticagrelor

I-Sacubitril Hemicalcium

I-Rivaroxaban

I-Pregabalin

Enalapril Maleate

I-Doxycycline Monohydrate

I-Chlorothiazide

I-Apixaban

Umlando Wenkampani

I-CPF yasungulwa edolobheni laseChangzhou ngonyaka we-1949

I-API yethu, i-Hydrochlorothiazide ivunywe yi-USFDA.

Uthole isitifiketi se-CEP se-Hydrochlorothiazide

Kugunyazwe yi-US. Ukuhlolwa kwe-FDA izikhathi eziyisi-9, kwadlula ukuhlolwa kwe-EU GMP izikhathi ezi-3

U-Nantong Chanyoo uphumelele ukuhlolwa kwe-EU GMP

I-Changzhou pharma. Futhi i-Nantong Chanyoo ivunywe yi-US FDA, i-Changzhou wuxin egunyazwe yi-Chinese GMP.

Amaphilisi e-Rs agunyaze ukuhlolwa kwesayithi kwe-US FDA. I-Nantong Chanyoo igunyazwe yi-PMDA.

I-Changzhou pharma. Igunyazwe yi-PMDA; iqedile umhlangano wokucobelelana ngolwazi ovunywe yi-US FDA.

I-China GMP igunyaze kokubili i-API kanye nemikhiqizo eqediwe futhi.

I-Changzhou pharma kanye ne-Nantong Chanyoo zigunyazwe ukuhlolwa okujwayelekile kwe-FDA.

Silwela ukunikeza amakhasimende imikhiqizo esezingeni. Cela ulwazi, Isampula & Quote, Xhumana nathi!